Trial intelligence / Profile preview

Zinc supplementation for immune function in sepsis

jRCTs051220200Completed

Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of zinc acetate in sepsis. Primary endpoint: Peripheral blood lymphocyte count at Day 15. Started Mar 2023; status: completed.

02

Drugs

zinc acetate
03

Conditions

sepsis

Beyond the preview

Go deeper on jRCTs051220200.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs051220200.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call